Medical application of phenazopyridine hydrochloride
The invention discloses medical application of phenazopyridine hydrochloride. The invention aims to solve the technical problem of how to treat or/and prevent diseases caused by coronavirus (CoV) or CoV infection. To solve the technical problem, the invention provides the application of phenazopyridine hydrochloride or phenazopyridine. The application comprises the following (a) and/or (b) and/or(c): (a) preparation of a drug for treating the diseases caused by CoV or CoV infection; (b) preparation of a drug for preventing the diseases caused by CoV or CoV infection; and (c) preparation of aCoV inhibitor. The medical application lays a foundation for further application of the phenazopyridine hydrochloride in treating diseases such as viral pneumonia and severe acute respiratory syndromecaused by 2019-nCoV..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 07. Juli Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
CEN SHAN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-07-07, Last update posted on www.tib.eu: 2022-04-09, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN111374985 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA006153100 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006153100 | ||
| 003 | DE-627 | ||
| 005 | 20230503175811.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA006153100 | ||
| 035 | |a (EPA)CN111374985 | ||
| 035 | |a (EPA)71213492 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a CEN SHAN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medical application of phenazopyridine hydrochloride |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-07-07, Last update posted on www.tib.eu: 2022-04-09, Last updated: 2023-02-09 | ||
| 520 | |a The invention discloses medical application of phenazopyridine hydrochloride. The invention aims to solve the technical problem of how to treat or/and prevent diseases caused by coronavirus (CoV) or CoV infection. To solve the technical problem, the invention provides the application of phenazopyridine hydrochloride or phenazopyridine. The application comprises the following (a) and/or (b) and/or(c): (a) preparation of a drug for treating the diseases caused by CoV or CoV infection; (b) preparation of a drug for preventing the diseases caused by CoV or CoV infection; and (c) preparation of aCoV inhibitor. The medical application lays a foundation for further application of the phenazopyridine hydrochloride in treating diseases such as viral pneumonia and severe acute respiratory syndromecaused by 2019-nCoV. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WANG YUJIA |4 aut | |
| 700 | 0 | |a LYU KAI |4 aut | |
| 700 | 0 | |a ZHAO JIANYUAN |4 aut | |
| 700 | 0 | |a GUO SAISAI |4 aut | |
| 700 | 0 | |a MA LING |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 07. Juli |
| 773 | 1 | 8 | |g year:2020 |g day:07 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/71213492/publication/CN111374985A1?q=CN111374985 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 07 |c 07 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 07 |c 07 | ||